PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood
Clinical trial NCT01509560 · COMPLETED
Trial details
- NCT number
- NCT01509560
- Sponsor
- Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2016-04-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.